PureTech Health PLC banner

PureTech Health PLC
NASDAQ:PRTC

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
NASDAQ:PRTC
Watchlist
Price: 17.51 USD 1.45% Market Closed
Market Cap: $419m

Wall St Price Targets

PRTC Price Targets Summary
PureTech Health PLC

Wall Street analysts forecast PRTC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRTC is 71.15 USD with a low forecast of 70.46 USD and a high forecast of 73.25 USD.

Lowest Forecast
Price Target
70.46 USD
302% Upside
Average Forecast
Price Target
71.15 USD
306% Upside
Highest Forecast
Price Target
73.25 USD
318% Upside
PureTech Health PLC Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
45% Upside
HCAT
Health Catalyst Inc
50% Upside

Revenue
Forecast

-5% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
38%
Average Beat
-5% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
38%
Average Beat

Over the last 11 years, the compound annual growth rate for Revenue has been -5%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PRTC's stock price target?
Price Target
71.15 USD

According to Wall Street analysts, the average 1-year price target for PRTC is 71.15 USD with a low forecast of 70.46 USD and a high forecast of 73.25 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett